Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.83
-0.51 (-4.13%)
At close: Mar 20, 2026, 4:00 PM EDT
11.70
-0.13 (-1.10%)
After-hours: Mar 20, 2026, 7:26 PM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $3.72 billion as of March 20, 2026. Its market cap has increased by 37.08% in one year.
Market Cap
3.72B
Enterprise Value
6.12B
1-Year Change
37.08%
Ranking
Category
Stock Price
$11.83
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $3.72B, an increase of 95.22%. That is a compound annual growth rate of 8.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.72B | -6.03% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 5.51B |
| Lantheus Holdings | 5.04B |
| Alkermes | 4.73B |
| Kiniksa Pharmaceuticals International, | 3.49B |
| Liquidia | 3.29B |
| Prestige Consumer Healthcare | 2.84B |
| Supernus Pharmaceuticals | 2.81B |
| BioCryst Pharmaceuticals | 2.46B |